HTR3C: Difference between revisions

Content deleted Content added
m v2.04b - Bot T23 CW#558 - Fix errors for CW project (Duplicated reference)
Monkbot (talk | contribs)
m Task 18 (cosmetic): eval 5 templates: del empty params (4×);
Line 1:
{{Infobox_gene}}
 
'''5-hydroxytryptamine receptor 3C''' is a [[protein]] that in humans is encoded by the ''HTR3C'' [[gene]].<ref name="pmid12801637">{{cite journal |vauthors=Niesler B, Frank B, Kapeller J, Rappold GA | title = Cloning, physical mapping and expression analysis of the human 5-HT3 serotonin receptor-like genes HTR3C, HTR3D and HTR3E | journal = Gene | volume = 310 | issue = | pages = 101–11 |date=Jun 2003 | pmid = 12801637 | pmc = | doi =10.1016/S0378-1119(03)00503-1 }}</ref><ref name="pmid15157181">{{cite journal |vauthors=Peters JA, Kelley SP, Dunlop JI, Kirkness EF, Hales TG, Lambert JJ | title = The 5-hydroxytryptamine type 3 (5-HT3) receptor reveals a novel determinant of single-channel conductance | journal = Biochem Soc Trans | volume = 32 | issue = Pt3 | pages = 547–52 |date=May 2004 | pmid = 15157181 | pmc = | doi = 10.1042/BST0320547 }}</ref> The protein encoded by this gene is a subunit of the [[5-HT3 receptor]].<ref name="pmid15157181" />
 
==References==
Line 8:
==Further reading==
{{refbegin | 2}}
*{{cite journal |vauthors=Karnovsky AM, Gotow LF, McKinley DD, etal |title=A cluster of novel serotonin receptor 3-like genes on human chromosome 3. |journal=Gene |volume=319 |issue= |pages= 137–48 |year= 2003 |pmid= 14597179 |doi=10.1016/S0378-1119(03)00803-5 }}
*{{cite journal |vauthors=Fasching PA, Kollmannsberger B, Strissel PL, etal |title=Polymorphisms in the novel serotonin receptor subunit gene HTR3C show different risks for acute chemotherapy-induced vomiting after anthracycline chemotherapy. |journal=J. Cancer Res. Clin. Oncol. |volume=134 |issue= 10 |pages= 1079–86 |year= 2008 |pmid= 18389280 |doi= 10.1007/s00432-008-0387-1 |s2cid=7504731 }}
*{{cite journal |vauthors=Ward MB, Kotasek D, McKinnon RA |title=Investigation of HTR3C mutations for association with 5HT(3) receptor antagonist anti-emetic efficacy. |journal=Pharmacogenomics |volume=9 |issue= 8 |pages= 1027–33 |year= 2008 |pmid= 18681779 |doi= 10.2217/14622416.9.8.1027 }}